for the international STI571 CML study group. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia - Kantarjian, H; Sawers, C; Hochhaus, A; Guilhot, F; Schiffer, C; Gambacorti-Passerini, C; Niederwieser, D; Resta, D; Capdeville, R; Zoellner, U; Talpaz, M; Druker, B (N Engl J Med, 2002)